Small molecule compounds targeting miRNAs for cancer therapy

Paloma del C. Monroig, Lu Chen, Shuxing Zhang, George A. Calin

Research output: Contribution to journalReview articlepeer-review

128 Scopus citations

Abstract

One of the most fascinating discoveries in molecular oncology has been that cancer represents a disease in which genetic alterations in protein-coding, but also in non-coding genes complement each other. MicroRNAs (miRNAs) are a type of non-coding RNA (ncRNA) transcripts that can regulate gene expression primarily by disrupting messenger RNA (mRNA) translation and/or stability, or alternatively by modulating the transcription of target mRNAs. For the last decade, miRNAs have shown to be pivotal characters of every single one of the cancer hallmarks. Profiling studies have proven the significance of identifying over-expressed miRNAs (oncomiRs) causative of the activation of oncogenic pathways that lead to malignancy. Due to their crucial role in cancer, it has become a challenge to develop efficient miRNA-inhibiting strategies such as antagomiRs, locked nucleic acids or antisense oligonucleotides. However, to this date, the accessible delivery agents and their pharmacokinetic/pharmacodynamic properties are not ideal. Thus there is an urgent, unmet need to develop miRNA-based inhibitory therapeutics. Herein we present a novel therapeutic strategy that is only at the tip of the iceberg: the use of small molecule inhibitors to target specific miRNAs (SMIRs). Furthermore we describe several high-throughput techniques to screen for SMIRs both in vitro and in silico. Finally we take you through the journey that has led to discovering the handful of SMIRs that have been validated to this date.

Original languageEnglish (US)
Pages (from-to)104-116
Number of pages13
JournalAdvanced Drug Delivery Reviews
Volume81
DOIs
StatePublished - Jan 1 2015

Keywords

  • Cancer
  • MicroRNAs
  • Non-coding RNAs
  • Small molecules
  • Targeted therapies

ASJC Scopus subject areas

  • Pharmaceutical Science

Fingerprint

Dive into the research topics of 'Small molecule compounds targeting miRNAs for cancer therapy'. Together they form a unique fingerprint.

Cite this